What is 9T Labs?
Founded in 2018 as a spin-off from the Federal Institute of Technology (ETH) in Zurich, 9T Labs is at the forefront of developing innovative 3D printers for carbon composite parts. These materials, renowned for their exceptional strength-to-weight ratio—five times lighter than steel—are critical for industries such as aerospace and medical prosthetics. The company's proprietary 3D printing process addresses the high costs associated with traditional carbon composite production, positioning 9T Labs as a key player in making advanced materials more accessible.
How much funding has 9T Labs raised?
9T Labs has raised a total of $21.5M across 2 funding rounds:
Angel/Seed
$4.5M
Series A
$17M
Angel/Seed (2020): $4.5M, investors not publicly disclosed
Series A (2022): $17M led by Stratasys and Verve Ventures
Key Investors in 9T Labs
Stratasys
Stratasys, a pioneer in additive manufacturing solutions since 1989, provides advanced systems for product design and manufacturing, focusing on creating parts for both prototyping and end-use applications.
Verve Ventures
Verve Ventures is a European venture capital firm that leverages its extensive network and technology-driven approach to invest in promising digital, tangible, and health & bio startups from Seed to Series B stages.
What's next for 9T Labs?
The recent major enterprise-level funding, including a significant strategic investment, signals a pivotal phase for 9T Labs. This capital infusion is expected to accelerate the finalization of their 3D printer development and facilitate the market launch of their groundbreaking technology. The company is poised to scale its operations, expand its market reach, and further solidify its position in the additive manufacturing landscape, potentially disrupting traditional manufacturing methods in high-demand sectors.
See full 9T Labs company page
